Artificial Intelligence-Powered Cognitive Behavioral Therapy Chatbots, a Systematic Review
,
Abstract
Objective: This review identifies the characteristic features of artificial intelligence (AI) chatbots and their therapeutic effect; assesses their efficacy in treatment of depression, anxiety, and other mental health disorders; and establishes levels of user engagement and satisfaction.
Method: Searches were conducted on the PubMed, Embase, MEDLINE, CENTRAL, CINAHL, PsycINFO, and Google Scholar databases using a set of keywords such as, not limited to, AI cognitive behavioral therapy (AI CBT), Youper, Wysa, Woebot, and other related terms. We included studies that were empirical, peer-reviewed, conducted between January 2017 and June 2024, and primarily focused on efficacy regarding the interventions and therapeutic outcomes. Data were then extracted and analyzed using both qualitative and quantitative methods concerning the mental health outcome.
Results: Our review identified large improvements across the three chatbots in symptoms of mental health, as supported by the 10 included studies: five on Woebot, four on Wysa, and one on Youper. Woebot showed remarkable reductions in depression and anxiety with high user engagement; Wysa demonstrated similar improvements, especially in users with chronic pain or maternal mental health challenges; Youper also presented a significant symptom reduction, including a 48% decrease in depression and a 43% decrease in anxiety. Common benefits of all chatbots were the therapeutic alliance and a high rate of satisfaction among users. We have also discussed the included studies’ limitations; that is, study design shortcomings and lack of sample diversity.
Conclusion: AI CBT chatbots, including but not limited to Woebot, Wysa, and Youper, are highly promising because of their availability and effectiveness in mental health support. They provide a useful complement to standard therapy when professional help is unavailable, and offer constant engagement with tailored interventions. However, it is necessary that further studies investigate their potential impact as long-term intervention models and explore how they may be integrated into holistic mental health care systems.
2. Mohammadi MR, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR, et al. An epidemiological survey of psychiatric disorders in Iran. Clin Pract Epidemiol Ment Health. 2005;1:16.
3. Arias D, Saxena S, Verguet S. Quantifying the global burden of mental disorders and their economic value. EClinicalMedicine. 2022;54:101675.
4. Andersson G, Cuijpers P. Pros and cons of online cognitive-behavioural therapy. Br J Psychiatry. 2008;193(4):270-1.
5. Beck JS. Cognitive behavior therapy: Basics and beyond: Guilford Publications; 2020.
6. Beck AT, Rush AJ, Shaw BF, Emery G, DeRubeis RJ, Hollon SD. Cognitive therapy of depression: Guilford Publications; 2024.
7. Meuret AE, Tunnell N, Roque A. Anxiety Disorders and Medical Comorbidity: Treatment Implications. Adv Exp Med Biol. 2020;1191:237-61.
8. Schmitt JC, Valiente RM, García-Escalera J, Arnáez S, Espinosa V, Sandín B, et al. Prevention of Depression and Anxiety in Subclinical Adolescents: Effects of a Transdiagnostic Internet-Delivered CBT Program. Int J Environ Res Public Health. 2022;19(9):5365.
9. Christ C, Schouten MJ, Blankers M, van Schaik DJ, Beekman AT, Wisman MA, et al. Internet and Computer-Based Cognitive Behavioral Therapy for Anxiety and Depression in Adolescents and Young Adults: Systematic Review and Meta-Analysis. J Med Internet Res. 2020;22(9):e17831.
10. Shklarski L, Abrams A, Bakst E. Will We Ever Again Conduct in-Person Psychotherapy Sessions? Factors Associated with the Decision to Provide in-Person Therapy in the Age of COVID-19. J Contemp Psychother. 2021;51(3):265-72.
11. Cowan A, Johnson R, Close H. Telepsychiatry in Psychotherapy Practice. Innov Clin Neurosci. 2020;17(4-6):23-6.
12. Bennett CB, Ruggero CJ, Sever AC, Yanouri L. eHealth to redress psychotherapy access barriers both new and old: A review of reviews and meta-analyses. J Psychother Integr. 2020;30(2):188.
13. Lee J, Lee D. User perception and self-disclosure towards an AI psychotherapy chatbot according to the anthropomorphism of its profile picture. Telemat Inform. 2023;85:102052.
14. Lee J, Lee D, Lee J-g. Influence of rapport and social presence with an AI psychotherapy chatbot on users’ self-disclosure. International Journal of Human–Computer Interaction. 2024;40(7):1620-31.
15. Yonatan‐Leus R, Brukner H. Comparing perceived empathy and intervention strategies of an AI chatbot and human psychotherapists in online mental health support. Couns Psychother Res. 2024.
16. Darcy A, Daniels J, Salinger D, Wicks P, Robinson A. Evidence of Human-Level Bonds Established With a Digital Conversational Agent: Cross-sectional, Retrospective Observational Study. JMIR Form Res. 2021;5(5):e27868.
17. Durden E, Pirner MC, Rapoport SJ, Williams A, Robinson A, Forman-Hoffman VL. Changes in stress, burnout, and resilience associated with an 8-week intervention with relational agent "Woebot". Internet Interv. 2023;33:100637.
18. Fitzpatrick KK, Darcy A, Vierhile M. Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial. JMIR Ment Health. 2017;4(2):e19.
19. Klos MC, Escoredo M, Joerin A, Lemos VN, Rauws M, Bunge EL. Artificial Intelligence-Based Chatbot for Anxiety and Depression in University Students: Pilot Randomized Controlled Trial. JMIR Form Res. 2021;5(8):e20678.
20. Prochaska JJ, Vogel EA, Chieng A, Baiocchi M, Maglalang DD, Pajarito S, et al. A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic. Drug Alcohol Depend. 2021;227:108986.
21. Prochaska JJ, Vogel EA, Chieng A, Kendra M, Baiocchi M, Pajarito S, et al. A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study. J Med Internet Res. 2021;23(3):e24850.
22. Thoma N, Pilecki B, McKay D. Contemporary Cognitive Behavior Therapy: A Review of Theory, History, and Evidence. Psychodyn Psychiatry. 2015;43(3):423-61.
23. Beatty C, Malik T, Meheli S, Sinha C. Evaluating the Therapeutic Alliance With a Free-Text CBT Conversational Agent (Wysa): A Mixed-Methods Study. Front Digit Health. 2022;4:847991.
24. Inkster B, Kadaba M, Subramanian V. Understanding the impact of an AI-enabled conversational agent mobile app on users' mental health and wellbeing with a self-reported maternal event: a mixed method real-world data mHealth study. Front Glob Womens Health. 2023;4:1084302.
25. Inkster B, Sarda S, Subramanian V. An Empathy-Driven, Conversational Artificial Intelligence Agent (Wysa) for Digital Mental Well-Being: Real-World Data Evaluation Mixed-Methods Study. JMIR Mhealth Uhealth. 2018;6(11):e12106.
26. Meheli S, Sinha C, Kadaba M. Understanding People With Chronic Pain Who Use a Cognitive Behavioral Therapy-Based Artificial Intelligence Mental Health App (Wysa): Mixed Methods Retrospective Observational Study. JMIR Hum Factors. 2022;9(2):e35671.
27. Mehta A, Niles AN, Vargas JH, Marafon T, Couto DD, Gross JJ. Acceptability and Effectiveness of Artificial Intelligence Therapy for Anxiety and Depression (Youper): Longitudinal Observational Study. J Med Internet Res. 2021;23(6):e26771.
28. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372:n71.
29. van Tulder M, Furlan A, Bombardier C, Bouter L. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine (Phila Pa 1976). 2003;28(12):1290-9.
30. Singh J. Critical appraisal skills programme. J Pharmacol Pharmacother. 2013;4(1):76-7.
31. Nahum-Shani I, Shaw SD, Carpenter SM, Murphy SA, Yoon C. Engagement in digital interventions. Am Psychol. 2022;77(7):836-52.
32. Lederman R, D'Alfonso S. The Digital Therapeutic Alliance: Prospects and Considerations. JMIR Ment Health. 2021;8(7):e31385.
33. Sucala M, Schnur JB, Brackman EH, Constantino MJ, Montgomery GH. Clinicians' attitudes toward therapeutic alliance in E-therapy. J Gen Psychol. 2013;140(4):282-93.
34. Hagi K, Kurokawa S, Takamiya A, Fujikawa M, Kinoshita S, Iizuka M, et al. Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomised controlled trials. Br J Psychiatry. 2023;223(3):407-14.
| Files | ||
| Issue | Vol 20 No 1 (2025) | |
| Section | Review Article(s) | |
| Keywords | ||
| Artificial Intelligence Anxiety Cognitive Behavioral Therapy Depression Substance-Related Disorders | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
